Evaluating Strategies to Control Hypercholesterolemia

Investigational Drug Study in Patients With Elevated Cholesterol and Coronary Heart Disease (0653-801)

NCT00092599 ·Status: COMPLETED ·Phase: PHASE3

A Pharmacokinetic and Pharmacodynamic Study of PF-04950615 (RN316) in Subjects With Hypercholesterolemia

NCT01435382 ·Status: COMPLETED ·Phase: PHASE1

Awareness of Chinese National Adult Lipid Treatment Guideline (2007) and Rate of Patients Achieving the Treatment Goal

NCT00781560 ·Status: COMPLETED

A Study of the Safety and Efficacy of Anacetrapib (MK-0859) Among Participants With Hypercholesterolemia When Added to Ongoing Statin Therapy (MK-0859-022)

NCT01860729 ·Status: COMPLETED ·Phase: PHASE3

A Confirmatory Trial of ETC-1002 in Patients With Hyper-LDL Cholesterolemia

NCT05683340 ·Status: COMPLETED ·Phase: PHASE3

Study of an Approved Drug With a Statin (a Medication That Lowers Cholesterol Levels) as Compared to Statin Therapy Alone in Patients With High Cholesterol (0653-040)

NCT00092586 ·Status: COMPLETED ·Phase: PHASE3

Improved Cardiovascular Disease hEALth Service Delivery in Australia: Cluster Randomised Controlled Trial (IDEAL Study)

NCT04896021 ·Status: COMPLETED ·Phase: NA

Coadministration of Ezetimibe and Atorvastatin in Patients With Primary Hypercholesterolemia (P05456)

NCT00654095 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Tolerability of Anacetrapib Added to Ongoing Lipid-Lowering Therapy in Adult Participants With Homozygous Familial Hypercholesterolemia (HoFH) (MK-0859-042)

NCT01841684 ·Status: TERMINATED ·Phase: PHASE3

EZETROL® Re-examination Study (MK0653-175)(COMPLETED)

NCT01070953 ·Status: COMPLETED

A Long-term Study of AK102 in Patients With Hypercholesterolemia

NCT04173403 ·Status: COMPLETED ·Phase: PHASE2

Coadministration of Ezetimibe and Simvastatin in Patients With Primary Hypercholesterolemia (P05457)

NCT00653523 ·Status: COMPLETED ·Phase: PHASE3

An Investigational Drug Study in Patients With Elevated Cholesterol and Coronary Heart Disease (0653-804)(COMPLETED)

NCT00092638 ·Status: COMPLETED ·Phase: PHASE3

A Prospective, Open Label Comparison of Ezetimibe, Niacin, and Colestipol as Adjunct Therapy in Lipid Reduction

NCT00203476 ·Status: COMPLETED ·Phase: PHASE4

Study to Compare Welchol and TriCor to TriCor Alone in Patients With High Cholesterol

NCT00754039 ·Status: COMPLETED ·Phase: PHASE4

Long-Term Safety and Tolerability of Ezetimibe (SCH 58235, MK-0653) With Atovastatin (P02154, MK-0653-017)

NCT03882892 ·Status: COMPLETED ·Phase: PHASE3

A Study to Determine the Degree of Additional Reduction in CV Risk in Lowering LDL Below Minimum Target Levels

NCT00327691 ·Status: COMPLETED ·Phase: PHASE4

Evaluation of ETC-1002 in Participants With Hypercholesterolemia and Hypertension

NCT02178098 ·Status: COMPLETED ·Phase: PHASE2

Evaluation of Safety and Efficacy of AVE5530 as add-on to Ongoing Statins in Patients With Primary Hypercholesterolemia

NCT00729027 ·Status: TERMINATED ·Phase: PHASE3

A Long-term Trial of ETC-1002 in Patients With Hyper-LDL Cholesterolemia

NCT05687071 ·Status: COMPLETED ·Phase: PHASE3

Cholesterol Lowering Level of MK0653A+Simvastatin in Patients With Hypercholesterolemia and Atherosclerotic or Coronary Vascular Disease (0653A-806)(COMPLETED)

NCT00090168 ·Status: COMPLETED ·Phase: PHASE3

Study to Assess the Tolerability and Efficacy of Anacetrapib in Patients With Coronary Heart Disease (CHD) or CHD Risk-Equivalent Disease (MK-0859-019)

NCT00685776 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the Efficacy and Safety of Co-administration of AD-2281 and AD-2282

NCT06747936 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3

An Extension Study of An Investigational Drug in Patients With Hypercholesterolemia (0653A-038)(COMPLETED)

NCT00092664 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the Efficacy and Safety of Co-administrated BR1018B and BR1018C

NCT06165250 ·Status: COMPLETED ·Phase: PHASE3